Efficacy and Safety of Pertuzumab and Trastuzumab Administered in a Single Infusion Bag, Followed by Vinorelbine: VELVET Cohort 2 Final Results

BACKGROUND. VELVET Cohort 1 demonstrated the applicability of pertuzumab, trastuzumab, and vinorelbine as an alternative first‐line treatment regimen for patients with HER2‐positive locally advanced or metastatic breast cancer (MBC) who cannot receive docetaxel. Co‐infusion of pertuzumab and trastuz...

Descripción completa

Detalles Bibliográficos
Autores principales: Andersson, Michael, López‐Vega, José M., Petit, Thierry, Zamagni, Claudio, Easton, Valerie, Kamber, Julia, Restuccia, Eleonora, Perez, Edith A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AlphaMed Press 2017
Materias:
Breast Cancer
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5634765/
https://www.ncbi.nlm.nih.gov/pubmed/28592618
http://dx.doi.org/10.1634/theoncologist.2017-0079

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5634765/
https://www.ncbi.nlm.nih.gov/pubmed/28592618
http://dx.doi.org/10.1634/theoncologist.2017-0079

Ejemplares similares